Additionally, recent preclinical studies have shown enhanced SYK activity, and greater sensitivity to SYK inhibition, in DLBCL tumor-cell lines with mutations in MYD88 and CD79b genes.

We came across a bullish thesis on Stryker Corporation (SYK) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on SYK. Stryker Corporation (SYK)’s share was ...

Date 10/18/2021 4:17:50 PM Share on Facebook ( MENAFN - GlobeNewsWire - Nasdaq) -- TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company's precision oncology pipeline ...